PeerVoice Endocrinology & Metabolic Disorders Audio
PeerVoice produces evidence-based medical education in Endocrinology & Metabolic Disorders, designed to improve patient care. Activities may be accredited or non-accredited, driven by the learning needs of healthcare professionals. The podcast features audio content from PeerVoice's educational programs.
Episodes
Raj Chovatiya, MD, PhD, MSCI - In Your Hands: A Case-Based Approach to Treating Moderate-to-Severe Chronic Hand Eczema
Raj Chovatiya, MD, PhD, MSCI - In Your Hands: A Case-Based Approach to Treating Moderate-to-Severe Chronic Hand Eczema
Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic Health
Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic Health
Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic Disease
Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic Disease
Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday Practice
Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday Practice
Colin M. Dayan, MA, MBBS, FRCP, PhD - Innovation Through Immunomodulation: The Practicalities of Delaying the Progression of Type 1 Diabetes
Colin M. Dayan, MA, MBBS, FRCP, PhD - Innovation Through Immunomodulation: The Practicalities of Delaying the Progression of Type 1 Diabetes
Javier Ampuero, MD, PhD - Making MASH a Priority in Our Gastroenterology Practices: Why We Should and How We Can
Javier Ampuero, MD, PhD - Making MASH a Priority in Our Gastroenterology Practices: Why We Should and How We Can
Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established Therapies
Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established Therapies
Ira Goldberg, MD - Mastering the Fundamentals of Care for Chylomicronemia: Following the Patient Care Pathway From Differential Diagnosis to Modern Management
Ira Goldberg, MD - Mastering the Fundamentals of Care for Chylomicronemia: Following the Patient Care Pathway From Differential Diagnosis to Modern Management
Ira Goldberg, MD - The Expanding Treatment Landscape for Familial Chylomicronemia Syndrome: Exploring New Options and Opportunities
Ira Goldberg, MD - The Expanding Treatment Landscape for Familial Chylomicronemia Syndrome: Exploring New Options and Opportunities
John E. Anderson, MD / Richard J. Auchus, MD, PhD - Hypercortisolism and Difficult-to-Treat Cardiometabolic Disease: Therapeutic Developments and Clinical Advances Driving Meaningful Improvement in Patient Outcomes
John E. Anderson, MD / Richard J. Auchus, MD, PhD - Hypercortisolism and Difficult-to-Treat Cardiometabolic Disease: Therapeutic Developments and Clinical Advances Driving Meaningful Improvement in Patient Outcomes
Stuart C. Gordon, MD - Data-Driven Decision-Making in Primary Biliary Cholangitis: Evaluating the Expanding Evidence Base for PPAR Agonists
Stuart C. Gordon, MD - Data-Driven Decision-Making in Primary Biliary Cholangitis: Evaluating the Expanding Evidence Base for PPAR Agonists
David Jones, OBE, MD, PhD - New Options and Opportunities for Personalised Treatment of Primary Biliary Cholangitis: Have You Updated Your Approach?
David Jones, OBE, MD, PhD - New Options and Opportunities for Personalised Treatment of Primary Biliary Cholangitis: Have You Updated Your Approach?
Eva Diehl - Wiesenecker, MD - Rare Causes of Abdominal Pain: Differential Diagnosis of Uncommon but Diagnosable Causes in the Emergency Room
Eva Diehl - Wiesenecker, MD - Rare Causes of Abdominal Pain: Differential Diagnosis of Uncommon but Diagnosable Causes in the Emergency Room
Christie M. Ballantyne, MD - At the Forefront of the Latest Developments in FCS: Expert Perspectives on Emerging Evidence
Christie M. Ballantyne, MD - At the Forefront of the Latest Developments in FCS: Expert Perspectives on Emerging Evidence
Martin Metz, MD - Bringing Chronic Spontaneous Urticaria Under Control: Available and Anticipated Strategies for Escalating Treatment
Martin Metz, MD - Bringing Chronic Spontaneous Urticaria Under Control: Available and Anticipated Strategies for Escalating Treatment
Angela Kay Fitch, MD, FACP, MFOMA - Separating Signal From Noise: Overcoming the Challenges of Obesity Management in Real-World Clinical Practice
Angela Kay Fitch, MD, FACP, MFOMA - Separating Signal From Noise: Overcoming the Challenges of Obesity Management in Real-World Clinical Practice
Emma Guttman-Yassky, MD, PhD - Atopic Dermatitis and the 0X40 Pathway: Understanding the Therapeutic Potential of OX40 Inhibition in Atopic Dermatitis
Emma Guttman-Yassky, MD, PhD - Atopic Dermatitis and the 0X40 Pathway: Understanding the Therapeutic Potential of OX40 Inhibition in Atopic Dermatitis
Richard David Graham Leslie, MD, FRCP, FAoP - When Could Dysglycaemia in Adults Be Type 1 Diabetes? Expert Perspectives on Recognising and Addressing Diagnostic Complexities and Challenges
Richard David Graham Leslie, MD, FRCP, FAoP - When Could Dysglycaemia in Adults Be Type 1 Diabetes? Expert Perspectives on Recognising and Addressing Diagnostic Complexities and Challenges
Francesco Lapi, PharmD, PhD - Chronic, Painful, and Often Overlooked: Working Together to Optimise Outcomes in Hidradenitis Suppurativa
Francesco Lapi, PharmD, PhD - Chronic, Painful, and Often Overlooked: Working Together to Optimise Outcomes in Hidradenitis Suppurativa
Kris V. Kowdley, MD - Advancing Individualized Treatment Strategies in Patients With Primary Biliary Cholangitis
Kris V. Kowdley, MD - Advancing Individualized Treatment Strategies in Patients With Primary Biliary Cholangitis
Kevin Fernando, MBChB, BSC Hons (Med Sci), MSc Diabetes - The Many Faces of PBC: Recognising Opportunities to Optimise Identification and Intervention Across Diverse Patient Populations
Kevin Fernando, MBChB, BSC Hons (Med Sci), MSc Diabetes - The Many Faces of PBC: Recognising Opportunities to Optimise Identification and Intervention Across Diverse Patient Populations
Gregory Y. H. Lip, MD - Optimising Oral Anticoagulant Use in Atrial Fibrillation: The Role of Real-World Evidence in Informing, Individualising, and Improving Care
Gregory Y. H. Lip, MD - Optimising Oral Anticoagulant Use in Atrial Fibrillation: The Role of Real-World Evidence in Informing, Individualising, and Improving Care
Gideon Hirschfield, MB BChir, FRCP, PhD - Keeping Pace With the Latest in PBC: Practical Perspectives on What’s New and What’s Next
Gideon Hirschfield, MB BChir, FRCP, PhD - Keeping Pace With the Latest in PBC: Practical Perspectives on What’s New and What’s Next
Olga Kordonouri, MD - Confronting the Silent Progression of Type 1 Diabetes: Rationales and Roadmaps for Early Detection and Proactive Intervention
Olga Kordonouri, MD - Confronting the Silent Progression of Type 1 Diabetes: Rationales and Roadmaps for Early Detection and Proactive Intervention
Ian SD Roberts, MBChB, FRCPath / Joris Roelofs, MD, PhD - Best Practices in Renal Pathology: Avoiding Common Pitfalls in the Diagnostic Pathways for Glomerular Diseases
Ian SD Roberts, MBChB, FRCPath / Joris Roelofs, MD, PhD - Best Practices in Renal Pathology: Avoiding Common Pitfalls in the Diagnostic Pathways for Glomerular Diseases
Kris V. Kowdley, MD - Navigating Cases of PBC Alongside the Experts: Best Practices in Tracking Treatment Response and Targeting Contemporary Goals of Care
Kris V. Kowdley, MD - Navigating Cases of PBC Alongside the Experts: Best Practices in Tracking Treatment Response and Targeting Contemporary Goals of Care
Jonathan Barratt, PhD, FRCP / Joris Roelofs, MD, PhD - The Central Role of Renal Pathology in the Differential Diagnosis of Glomerular Diseases: Sharing Expertise, Experience, and Essential Next Steps
Jonathan Barratt, PhD, FRCP / Joris Roelofs, MD, PhD - The Central Role of Renal Pathology in the Differential Diagnosis of Glomerular Diseases: Sharing Expertise, Experience, and Essential Next Steps
Angela Fitch, MD, FACP, MFOMA - This Cannot Weight: A Specialist Guide to Weight Management and Obesity Associated With Emotional Eating Behaviours
Angela Fitch, MD, FACP, MFOMA - This Cannot Weight: A Specialist Guide to Weight Management and Obesity Associated With Emotional Eating Behaviours
Jonathan Barratt, PhD, FRCP - Redefining Hope: The IgA Nephropathy Journey
Jonathan Barratt, PhD, FRCP - Redefining Hope: The IgA Nephropathy Journey
Maria Craig, MBBS, PhD, FRACP, MMed(ClinEpid) - Treating T2D in People of Younger Age in This Day and Age: How Would You Manage These Children and Adolescents With T2D?
Maria Craig, MBBS, PhD, FRACP, MMed(ClinEpid) - Treating T2D in People of Younger Age in This Day and Age: How Would You Manage These Children and Adolescents With T2D?
Fatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes
Fatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes
George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action
George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action
Carel le Roux, MD, PhD - Prioritising Obesity Care in Our Clinical Practices: Why We Must and How We Can
Carel le Roux, MD, PhD - Prioritising Obesity Care in Our Clinical Practices: Why We Must and How We Can
Meena B. Bansal, MD, FAASLD - The Many Faces of MASH: Recognising Risk, Improving Identification, and Maximising Management in the Primary Care Setting
Meena B. Bansal, MD, FAASLD - The Many Faces of MASH: Recognising Risk, Improving Identification, and Maximising Management in the Primary Care Setting
Andreea Ciudin, MD, PhD - Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on the Modernisation of Obesity Care
Andreea Ciudin, MD, PhD - Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on the Modernisation of Obesity Care
Lise Lotte Gluud, MD - Following the Evidence-Based Road: Improving Care for MASH Through Use of Clinical Care Pathways in Primary Care
Lise Lotte Gluud, MD - Following the Evidence-Based Road: Improving Care for MASH Through Use of Clinical Care Pathways in Primary Care
Tina Vilsbøll, MD, DMSc - Overcoming Barriers to Basal Insulin in T2DM: Appreciating the Preferences and Perspectives of Patients With T2DM
Tina Vilsbøll, MD, DMSc - Overcoming Barriers to Basal Insulin in T2DM: Appreciating the Preferences and Perspectives of Patients With T2DM
Paolo Sbraccia, MD, PhD - Providing State of the Art Care for People With Obesity: Can We Break Free From the Status Quo?
Paolo Sbraccia, MD, PhD - Providing State of the Art Care for People With Obesity: Can We Break Free From the Status Quo?
Harpreet Bajaj, MD, MPH - Innovating Our Approach to the Initiation of Insulin in T2DM: The Why and the How
Harpreet Bajaj, MD, MPH - Innovating Our Approach to the Initiation of Insulin in T2DM: The Why and the How
Melanie J. Davies, CBE, FRCP, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established Therapies
Melanie J. Davies, CBE, FRCP, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established Therapies
Mansoor Husain, MD - Integrating GLP-1 RAs Into Our Cardiology Care Pathways: Who, When, and Why?
Mansoor Husain, MD - Integrating GLP-1 RAs Into Our Cardiology Care Pathways: Who, When, and Why?
Sarah Jarvis, MBE, FRCGP - Achieving Shared Goals Across the Spectrum of CKD and HF
Sarah Jarvis, MBE, FRCGP - Achieving Shared Goals Across the Spectrum of CKD and HF
Kieran McCafferty, MB BChir, MRCP, MD (res) / Shelley Zieroth, MD, FRCPC, FHFSA (hon) - Handling Hyperkalaemia Without Compromising Care for Chronic Kidney Disease and Heart Failure
Kieran McCafferty, MB BChir, MRCP, MD (res) / Shelley Zieroth, MD, FRCPC, FHFSA (hon) - Handling Hyperkalaemia Without Compromising Care for Chronic Kidney Disease and Heart Failure
Sarah Jarvis, MBE, FRCGP - Identifying Intervention Points in CKD and HF From Multidisciplinary Viewpoints
Sarah Jarvis, MBE, FRCGP - Identifying Intervention Points in CKD and HF From Multidisciplinary Viewpoints
Verónica Vázquez Velázquez, PhD - Optimising Obesity Care in Adolescent Patients: Practical Blueprints to Overcome Barriers
Verónica Vázquez Velázquez, PhD - Optimising Obesity Care in Adolescent Patients: Practical Blueprints to Overcome Barriers
George L. Bakris, MD, MA - Step-by-Step: Setting a Course for Managing CKD and T2DM With Nonsteroidal MRAs
George L. Bakris, MD, MA - Step-by-Step: Setting a Course for Managing CKD and T2DM With Nonsteroidal MRAs
Luis Alberto Moreno, MD, PhD / Aaron Kelly, PhD - Assessing and Alleviating the Weight of Obesity in Adolescent Patients
Luis Alberto Moreno, MD, PhD / Aaron Kelly, PhD - Assessing and Alleviating the Weight of Obesity in Adolescent Patients
Kevin Fernando, FRCGP, FRCP Edin., FAcadMEd - Simplified Strategies to Optimise Obesity Management for Primary Point of Contact Clinicians
Kevin Fernando, FRCGP, FRCP Edin., FAcadMEd - Simplified Strategies to Optimise Obesity Management for Primary Point of Contact Clinicians
Angela Fitch, MD, FACP, Dipl. ABOM - Give the Heart a Break: Improving Cardiovascular Risk and Outcomes With Modern Weight Management Strategies
Angela Fitch, MD, FACP, Dipl. ABOM - Give the Heart a Break: Improving Cardiovascular Risk and Outcomes With Modern Weight Management Strategies
Kausik Ray, MD, MPhil (Cantab), MBChB - Taking Obesity to Heart: The Role of the Cardiologist in Incorporating Obesity Care Into Cardiovascular Care to Enhance Patient Outcomes
Kausik Ray, MD, MPhil (Cantab), MBChB - Taking Obesity to Heart: The Role of the Cardiologist in Incorporating Obesity Care Into Cardiovascular Care to Enhance Patient Outcomes
Samuel Seidu, MD, FRCGP, FRCP (Edin) - The Power of the Primary Point of Contact: Taking Obesity From Obstacle to Opportunity
Samuel Seidu, MD, FRCGP, FRCP (Edin) - The Power of the Primary Point of Contact: Taking Obesity From Obstacle to Opportunity
Jens Lundgren, MD - Applying Current European Guidance on Treating COVID-19 in Hospitalized Patients
Jens Lundgren, MD - Applying Current European Guidance on Treating COVID-19 in Hospitalized Patients
Sharon Cohen, MD, FRCPC - Inflammation and the Brain: Why We Need To Know More
Sharon Cohen, MD, FRCPC - Inflammation and the Brain: Why We Need To Know More
Mauro Bernardi, MD - The Functional Quality of Albumin in Fluid Management of Patients with Liver Cirrhosis: Just a Concept or Does it Matter?
Mauro Bernardi, MD - The Functional Quality of Albumin in Fluid Management of Patients with Liver Cirrhosis: Just a Concept or Does it Matter?
Tali Cukierman-Yaffe, MD, MSc - Beyond Metabolic Benefits: Recognising and Reducing the Risk of Stroke in Type 2 Diabetes With GLP-1 RAs
Tali Cukierman-Yaffe, MD, MSc - Beyond Metabolic Benefits: Recognising and Reducing the Risk of Stroke in Type 2 Diabetes With GLP-1 RAs
Melanie J. Davies, CBE, FRCP, FMedSci - Clinical Challenges in Insulin Initiation: Overcoming Obstacles to Improved Glycaemic Control in Type 2 Diabetes
Melanie J. Davies, CBE, FRCP, FMedSci - Clinical Challenges in Insulin Initiation: Overcoming Obstacles to Improved Glycaemic Control in Type 2 Diabetes
Janaka Karalliedde, FRCP, PhD - Stroke Prevention in T2DM: The Neuroprotective Benefits of GLP-1 RAs
Janaka Karalliedde, FRCP, PhD - Stroke Prevention in T2DM: The Neuroprotective Benefits of GLP-1 RAs
Melanie J. Davies, CBE, FRCP, FMedSci - Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 Diabetes
Melanie J. Davies, CBE, FRCP, FMedSci - Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 Diabetes
Aoife Egan, MB, BCh, PhD - Insulin Resistance and Women’s Health: Case Studies in Gestational Diabetes and Polycystic Ovarian Syndrome
Aoife Egan, MB, BCh, PhD - Insulin Resistance and Women’s Health: Case Studies in Gestational Diabetes and Polycystic Ovarian Syndrome
"Pantelis Sarafidis, MD, MSc, PhD - Meeting the Challenge of Improving Outcomes in CKD and T2DM: A Call to Action for Clinicians
"
"Pantelis Sarafidis, MD, MSc, PhD - Meeting the Challenge of Improving Outcomes in CKD and T2DM: A Call to Action for Clinicians
"
Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?
Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?
Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real World
Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real World
Recommended
Pod Save America
Dateline NBC
صداستان: ساعتی با موسیقی
Becoming: HER with Nikki Spoelstra
Exposing Workplace Bullying
Everyday AI Made Simple - AI For Everyday Tasks
FemTech Focus
Not Too Sensitive - Empowering Highly Sensitive People (HSPs) To Own Their Sensitivity
Mother Daughter Relationship Show
Skin Deep MDs with Dr. Mamina Turegano, Dr. Lindsey Zubritsky and Dr. Jenny Liu
girl talk 🎧🫧
Booked, Blonde & Busy w/ Olivia Ponton
